Gerst Diane G. 4
4 · Amphastar Pharmaceuticals, Inc. · Filed Jul 19, 2022
Insider Transaction Report
Form 4
Gerst Diane G.
Corp. SVP of Quality Assurance
Transactions
- Exercise/Conversion
Stock Option (right to buy)
2022-07-18−1,520→ 1,336 totalExercise: $20.08Exp: 2028-06-08→ Common Stock (1,520 underlying) - Exercise/Conversion
Common Stock
2022-07-18$20.08/sh+1,520$30,522→ 14,362 total - Sale
Common Stock
2022-07-18$37.23/sh−1,520$56,597→ 12,842 total
Footnotes (3)
- [F1]The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 13, 2022.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.925 to $37.58, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
- [F3]Shares subject to the option are fully vested and immediately exercisable.